Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Tumor Burden"" wg kryterium: Temat


Tytuł :
[Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model].
Autorzy :
Tejera-Vaquerizo A; Servicio de Dermatología, Instituto Dermatológico GlobalDerm, Palma del Río, Córdoba, España. Electronic address: .
Cañueto J; Servicio de Dermatología, Hospital Universitario de Salamanca, Salamanca, España.
Toll A; Servicio de Dermatología, Hospital Clìnic de Barcelona, Barcelona, España.
Santos-Juanes J; Servicio de Dermatología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España.
Jaka A; Servicio de Dermatología, Hospital Germans Trial i Pujol, Badalona, Barcelona, España.
Ferrandiz-Pulido C; Servicio de Dermatología, Hospital Universitario Vall d'Hebron, Barcelona, España.
Sanmartín O; Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España.
Ribero S; Departamento de Dermatología, Hospital Universitario de Turín, Turín, Italia.
Moreno-Ramírez D; Unidad de Melanoma, Servicio de Dermatología Médico-Quirúrgica, Hospital Universitario Virgen Macarena, Sevilla, España.
Almazán F; Unidad de Gestión Clínica de Dermatología, Hospital Universitario San Cecilio, Granada, España.
Fuente MJ; Servicio de Dermatología, Hospital Germans Trial i Pujol, Badalona, Barcelona, España.
Podlipnik S; Servicio de Dermatología, Hospital Clìnic de Barcelona, Barcelona, España.
Nagore E; Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España.
Pokaż więcej
Transliterated Title :
Estimación del efecto en el tamaño y la supervivencia de los tumores cutáneos debido al confinamiento por COVID-19: modelo basado en un crecimiento exponencial.
Źródło :
Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2020 Oct; Vol. 111 (8), pp. 629-638. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Betacoronavirus*
Tumor Burden*
Carcinoma, Squamous Cell/*pathology
Coronavirus Infections/*epidemiology
Head and Neck Neoplasms/*pathology
Melanoma/*pathology
Pneumonia, Viral/*epidemiology
Skin Neoplasms/*pathology
Age Factors ; Algorithms ; Carcinoma, Squamous Cell/mortality ; Delayed Diagnosis/adverse effects ; Delayed Diagnosis/statistics & numerical data ; Female ; Head and Neck Neoplasms/mortality ; Health Services Accessibility ; Humans ; Male ; Melanoma/mortality ; Pandemics ; Public Health Surveillance/methods ; Quarantine ; Retrospective Studies ; Sex Factors ; Skin Neoplasms/mortality ; Spain/epidemiology ; Time Factors ; Time-to-Treatment
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
Combination of baseline total metabolic tumor volume measured on FDG-PET/CT and β2-microglobulin have a robust predictive value in patients with primary breast lymphoma.
Autorzy :
Zhao P; Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Zhu L; Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Song Z; Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Wang X; Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Ma W; Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Zhu X; Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Qiu L; Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Li L; Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Zhou S; Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Qian Z; Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Xu W; Department of Molecular Imaging and Nuclear Medicine, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Zhang H; Department of Lymphoma, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, P.R. China.
Pokaż więcej
Źródło :
Hematological oncology [Hematol Oncol] 2020 Oct; Vol. 38 (4), pp. 493-500. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :
Journal Article
MeSH Terms :
Tumor Burden*
Breast Neoplasms/*pathology
Fluorodeoxyglucose F18/*metabolism
Lymphoma/*pathology
Positron Emission Tomography Computed Tomography/*methods
beta 2-Microglobulin/*metabolism
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/metabolism ; Breast Neoplasms/therapy ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Lymphoma/diagnostic imaging ; Lymphoma/metabolism ; Lymphoma/therapy ; Middle Aged ; Prognosis ; Radiopharmaceuticals/metabolism ; Survival Rate ; Young Adult
Czasopismo naukowe
Tytuł :
Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
Autorzy :
Tsilimigras DI; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Mehta R; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Paredes AZ; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Moris D; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Sahara K; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Bagante F; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.; Department of Surgery, University of Verona, Verona, Italy.
Ratti F; Department of Surgery, Ospedale San Raffaele, Milano, Italy.
Marques HP; Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal.
Silva S; Department of Surgery, Curry Cabral Hospital, Lisbon, Portugal.
Soubrane O; Department of Hepatobiliopancreatic Surgery, APHP, Beaujon Hospital, Clichy, France.
Lam V; Department of Surgery, Westmead Hospital, Sydney, Australia.
Poultsides GA; Department of Surgery, Stanford University, Stanford, California.
Popescu I; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
Grigorie R; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
Alexandrescu S; Department of Surgery, Fundeni Clinical Institute, Bucharest, Romania.
Martel G; Department of Surgery, University of Ottawa, Ottawa, Canada.
Workneh A; Department of Surgery, University of Ottawa, Ottawa, Canada.
Guglielmi A; Department of Surgery, University of Verona, Verona, Italy.
Hugh T; Department of Surgery, The University of Sydney, School of Medicine, Sydney, Australia.
Aldrighetti L; Department of Surgery, Ospedale San Raffaele, Milano, Italy.
Endo I; Yokohama City University School of Medicine, Yokohama, Japan.
Spolverato G; Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.
Umberto C; Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.
Pawlik TM; Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio.
Pokaż więcej
Źródło :
Annals of surgery [Ann Surg] 2020 Oct; Vol. 272 (4), pp. 574-581.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatectomy*
Tumor Burden*
Carcinoma, Hepatocellular/*pathology
Carcinoma, Hepatocellular/*surgery
Liver Neoplasms/*pathology
Liver Neoplasms/*surgery
Aged ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Sequential Duo-Peptide Receptor Radionuclide Therapy With Indigenous 90Y-DOTATATE and 177Lu-DOTATATE in Large-Volume Neuroendocrine Tumors: Posttherapy Bremsstrahlung and PET/CT Imaging Following 90Y-DOTATATE Treatment.
Autorzy :
Parghane RV; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Mitra A; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Upadhye T; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Rakshit S; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Banerjee S; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Basu S; From the Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Centre Annexe, Mumbai.; Homi Bhabha National Institute, Mumbai, India.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2020 Sep; Vol. 45 (9), pp. 714-715.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Positron Emission Tomography Computed Tomography*
Tumor Burden*/radiation effects
Coordination Complexes/*therapeutic use
Neuroendocrine Tumors/*pathology
Neuroendocrine Tumors/*radiotherapy
Octreotide/*analogs & derivatives
Organometallic Compounds/*therapeutic use
Receptors, Peptide/*metabolism
Gallium Radioisotopes ; Humans ; Male ; Middle Aged ; Neuroendocrine Tumors/diagnostic imaging ; Neuroendocrine Tumors/metabolism ; Octreotide/therapeutic use
Czasopismo naukowe
Tytuł :
Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor.
Autorzy :
Yao Y; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Yao QY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Xue JS; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Tian XY; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
An QM; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Cui LX; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Xu C; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Su H; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Yang L; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Feng YY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.
Hao CY; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Institute, Beijing 100142, China. Electronic address: .
Zhou TY; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China. Electronic address: .
Pokaż więcej
Źródło :
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2020 Aug 15; Vol. 401, pp. 115118. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Agents, Hormonal/*therapeutic use
Dexamethasone/*therapeutic use
Pancreatic Neoplasms/*metabolism
Receptors, Glucocorticoid/*metabolism
Tumor Burden/*drug effects
Xenograft Model Antitumor Assays/*methods
A549 Cells ; Animals ; Antineoplastic Agents, Hormonal/pharmacology ; Dexamethasone/pharmacology ; Dose-Response Relationship, Drug ; Female ; Glucocorticoids/pharmacology ; Glucocorticoids/therapeutic use ; Humans ; MCF-7 Cells ; Mice, Inbred BALB C ; Mice, Nude ; Pancreatic Neoplasms/drug therapy ; Tumor Burden/physiology
Czasopismo naukowe
Tytuł :
Correlation of Pathological Complete Response With Tumor Volume Reduction During Neoadjuvant Chemoradiotherapy in Lung Cancer.
Autorzy :
Takahashi S; Department of Radiation Oncology, Kagawa University Hospital, Kagawa, Japan .
Go T; Department of General Thoracic, Breast and Endocrine Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Anada M; Department of Radiation Oncology, Kagawa University Hospital, Kagawa, Japan.
Kinoshita T; Department of Radiation Oncology, Kagawa University Hospital, Kagawa, Japan.
Nishide T; Department of Radiation Oncology, Kagawa University Hospital, Kagawa, Japan.
Yokomise H; Department of General Thoracic, Breast and Endocrine Surgery, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Shibata T; Department of Radiation Oncology, Kagawa University Hospital, Kagawa, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Aug; Vol. 40 (8), pp. 4327-4330.
Typ publikacji :
Journal Article
MeSH Terms :
Neoadjuvant Therapy*
Tumor Burden*
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Carcinoma, Non-Small-Cell Lung/pathology ; Chemoradiotherapy ; Humans ; Lung Neoplasms/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate Cancer.
Autorzy :
Schmidkonz C; From the Department of Nuclear Medicine.
Götz TI; From the Department of Nuclear Medicine.
Atzinger A; From the Department of Nuclear Medicine.
Ritt P; From the Department of Nuclear Medicine.
Prante O; From the Department of Nuclear Medicine.
Kuwert T; From the Department of Nuclear Medicine.
Bäuerle T; Institute of Radiology.
Goebell P; Department of Urology and Pediatric Urology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany.
Cordes M; From the Department of Nuclear Medicine.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2020 Aug; Vol. 45 (8), pp. e349-e357.
Typ publikacji :
Journal Article
MeSH Terms :
Organotechnetium Compounds*
Single Photon Emission Computed Tomography Computed Tomography*
Tumor Burden*
Prostatic Neoplasms/*diagnostic imaging
Prostatic Neoplasms/*therapy
Aged ; Androgen Antagonists/therapeutic use ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Grading ; Prostatic Neoplasms/metabolism ; Prostatic Neoplasms/pathology ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Giant Mesenteric Mixed Hemangioma Misdiagnosed as Ovarian Cyst: A Case Report and a Literature Review.
Autorzy :
Wu F; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
Hu M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
Cao M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China. Electronic address: .
Ou M; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
Li Q; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
Liu Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.
Pokaż więcej
Źródło :
Annals of vascular surgery [Ann Vasc Surg] 2020 Aug; Vol. 67, pp. 567.e1-567.e4. Date of Electronic Publication: 2020 Mar 21.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Tumor Burden*
Hemangioma/*diagnostic imaging
Ovarian Cysts/*diagnostic imaging
Peritoneal Neoplasms/*diagnostic imaging
Adult ; Diagnostic Errors ; Female ; Hemangioma/pathology ; Hemangioma/surgery ; Humans ; Ovarian Cysts/pathology ; Peritoneal Neoplasms/pathology ; Peritoneal Neoplasms/surgery ; Predictive Value of Tests
Czasopismo naukowe
Tytuł :
Sentinel node tumor burden in prediction of prognosis in melanoma patients.
Autorzy :
Palve J; Department of Plastic Surgery, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Teiskontie 35, 33521, Tampere, Finland. .
Ylitalo L; Department of Dermatology, Skin Cancer Unit, Helsinki University Central Hospital, Helsinki, Finland.; Department of Dermatology and Allergology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Luukkaala T; Research, Development and Innovation Center, Tampere University Hospital and Health Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Jernman J; Department of Pathology, Tampere University and Fimlab Laboratories, Tampere, Finland.
Korhonen N; Department of Dermatology and Allergology, Tampere University Hospital and Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Pokaż więcej
Źródło :
Clinical & experimental metastasis [Clin Exp Metastasis] 2020 Apr; Vol. 37 (2), pp. 365-376. Date of Electronic Publication: 2020 Feb 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Tumor Burden*
Lymphatic Metastasis/*pathology
Melanoma/*mortality
Sentinel Lymph Node/*pathology
Skin Neoplasms/*mortality
Aged ; Chemotherapy, Adjuvant ; Female ; Follow-Up Studies ; Humans ; Lymph Node Excision/statistics & numerical data ; Lymphatic Metastasis/therapy ; Male ; Melanoma/pathology ; Melanoma/therapy ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Retrospective Studies ; Risk Assessment ; Sentinel Lymph Node/surgery ; Sentinel Lymph Node Biopsy/statistics & numerical data ; Skin Neoplasms/pathology ; Skin Neoplasms/therapy
Czasopismo naukowe
Tytuł :
Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients.
Autorzy :
Fathi AH; 8785 Department of Surgery, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA.
Romanyshyn J; 8785 Department of Surgery, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA.
Barati M; University of Southern Mississippi, Hattiesburg, MS, USA.
Choudhury U; 8785 Department of Surgery, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA.
Chen A; 8785 Department of Surgery, University of California San Francisco, Fresno Medical Education Program, Fresno, CA, USA.
Sosa JA; 8785 Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
Pokaż więcej
Źródło :
The American surgeon [Am Surg] 2020 May; Vol. 86 (5), pp. 458-466.
Typ publikacji :
Journal Article
MeSH Terms :
Tumor Burden*
Neuroendocrine Tumors/*mortality
Neuroendocrine Tumors/*pathology
Pancreatic Neoplasms/*mortality
Pancreatic Neoplasms/*pathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Survival Rate ; Young Adult
SCR Disease Name :
Non functioning pancreatic endocrine tumor
Czasopismo naukowe
Tytuł :
Improving Delineation of True Tumor Volume With Multimodal MRI in a Rat Model of Brain Metastasis.
Autorzy :
Larkin JR; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford.
Simard MA; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford.
de Bernardi A; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford.
Johanssen VA; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford.
Perez-Balderas F; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford.
Sibson NR; Department of Oncology, Cancer Research UK and Medical Research Council Oxford Institute for Radiation Oncology, University of Oxford. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Apr 01; Vol. 106 (5), pp. 1028-1038. Date of Electronic Publication: 2020 Jan 17.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Magnetic Resonance Imaging*
Multimodal Imaging*
Tumor Burden*/radiation effects
Brain Neoplasms/*pathology
Brain Neoplasms/*secondary
Animals ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/radiotherapy ; Female ; Image Processing, Computer-Assisted ; Rats
Czasopismo naukowe
Tytuł :
The Influence of Vestibular Schwannoma Tumor Volume and Growth on Hearing Loss.
Autorzy :
Patel NS; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Huang AE; Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Dowling EM; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Lees KA; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Tombers NM; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Lohse CM; Department of Health Science Research, Mayo Clinic, Rochester, Minnesota, USA.
Marinelli JP; Alix School of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Van Gompel JJ; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Neff BA; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Driscoll CLW; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Link MJ; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Carlson ML; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.; Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Pokaż więcej
Źródło :
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery [Otolaryngol Head Neck Surg] 2020 Apr; Vol. 162 (4), pp. 530-537. Date of Electronic Publication: 2020 Jan 28.
Typ publikacji :
Journal Article
MeSH Terms :
Tumor Burden*
Hearing Loss/*etiology
Neuroma, Acoustic/*complications
Neuroma, Acoustic/*pathology
Aged ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Patient Demographics Influencing Vestibular Schwannoma Size and Initial Management Plans.
Autorzy :
Ostler B; Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Killeen DE; Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Reisch J; Department of Clinical Sciences, Division of Biostatistics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Barnett S; Department of Neurosurgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Kutz JW Jr; Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Isaacson B; Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Hunter JB; Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address: .
Pokaż więcej
Źródło :
World neurosurgery [World Neurosurg] 2020 Apr; Vol. 136, pp. e440-e446. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji :
Journal Article
MeSH Terms :
Tumor Burden*
Neuroma, Acoustic/*pathology
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Female ; Humans ; Insurance Coverage/statistics & numerical data ; Insurance, Health/statistics & numerical data ; Male ; Marital Status ; Middle Aged ; Neuroma, Acoustic/therapy ; Patient Care Planning ; Residence Characteristics/statistics & numerical data ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł :
Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation.
Autorzy :
Lombard A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, UK. .; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PT, UK. .
Mistry H; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PT, UK.; Division of Cancer Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PT, UK.
Chapman SC; Eli Lilly and Company, Erl Wood Manor, Windlesham, UK.
Gueoguieva I; Eli Lilly and Company, Erl Wood Manor, Windlesham, UK.
Aarons L; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, UK.; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PT, UK.
Ogungbenro K; Centre for Applied Pharmacokinetic Research, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, UK.; Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, M13 9PT, UK.
Pokaż więcej
Źródło :
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2020 Apr; Vol. 85 (4), pp. 817-825. Date of Electronic Publication: 2020 Mar 13.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Models, Statistical*
Observer Variation*
Response Evaluation Criteria in Solid Tumors*
Tumor Burden*
Antineoplastic Agents/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*pathology
Lung Neoplasms/*pathology
Carcinoma, Non-Small-Cell Lung/drug therapy ; Clinical Trials, Phase III as Topic ; Humans ; Lung Neoplasms/drug therapy ; Multicenter Studies as Topic
Czasopismo naukowe
Tytuł :
PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability.
Autorzy :
Pfaehler E; Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Burggraaff C; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Kramer G; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Zijlstra J; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Hoekstra OS; Department of Oncology Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Jalving M; Department of Oncology Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Noordzij W; Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Brouwers AH; Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Stevenson MG; Department of Surgical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
de Jong J; Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Boellaard R; Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Mar 30; Vol. 15 (3), pp. e0230901. Date of Electronic Publication: 2020 Mar 30 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Algorithms*
Positron-Emission Tomography*
Tumor Burden*
Workflow*
Image Processing, Computer-Assisted/*methods
Neoplasms/*diagnostic imaging
Neoplasms/*pathology
Humans ; Observer Variation
Czasopismo naukowe
Tytuł :
Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center.
Autorzy :
Liu YW; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Lin CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Yong CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Wang CC; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Chen CL; Liver Transplantation Center and Department of Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Wang JH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Yen YH; Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Mar 27; Vol. 15 (3), pp. e0230897. Date of Electronic Publication: 2020 Mar 27 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Tumor Burden*
Ambulatory Care Facilities/*statistics & numerical data
Carcinoma, Hepatocellular/*pathology
Carcinoma, Hepatocellular/*surgery
Liver Neoplasms/*pathology
Liver Neoplasms/*surgery
Aged ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł :
Tumour length as an independent prognostic factor in resectable oesophageal carcinoma.
Autorzy :
Vadhwana B; Queens Hospital, Romford, UK.
Zosimas D; Queens Hospital, Romford, UK.
Lykoudis PM; University College London, London, UK.
Phen HM; Queens Hospital, Romford, UK.
Martinou M; Queens Hospital, Romford, UK.
Khoo D; Queens Hospital, Romford, UK.
Pokaż więcej
Źródło :
Annals of the Royal College of Surgeons of England [Ann R Coll Surg Engl] 2020 Mar; Vol. 102 (3), pp. 185-190. Date of Electronic Publication: 2019 Nov 22.
Typ publikacji :
Journal Article
MeSH Terms :
Tumor Burden*
Adenocarcinoma/*surgery
Carcinoma, Squamous Cell/*surgery
Esophageal Neoplasms/*pathology
Esophageal Neoplasms/*surgery
Neoplasm Recurrence, Local/*pathology
Adenocarcinoma/secondary ; Aged ; Carcinoma, Squamous Cell/secondary ; Female ; Humans ; Lymphatic Metastasis ; Male ; Middle Aged ; Progression-Free Survival ; Survival Rate
Czasopismo naukowe
Tytuł :
Rate of change in maximum F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas.
Autorzy :
Oughourlian TC; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Yao J; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Bioengineering, Henry Samueli School of Engineering, University of California Los Angeles, Los Angeles, CA, USA.
Schlossman J; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Raymond C; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Ji M; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Tatekawa H; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Salamon N; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Pope WB; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Czernin J; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Nghiemphu PL; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Lai A; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Cloughesy TF; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Ellingson BM; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. .; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. .; Neuroscience Interdepartmental Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. .; Department of Bioengineering, Henry Samueli School of Engineering, University of California Los Angeles, Los Angeles, CA, USA. .; UCLA Brain Tumor Imaging Laboratory, Departments of Radiological Sciences and Psychiatry, David Geffen School of Medicine, University of California Los Angeles, 924 Westwood Blvd., Suite 615, Los Angeles, CA, 90024, USA. .
Pokaż więcej
Źródło :
Journal of neuro-oncology [J Neurooncol] 2020 Mar; Vol. 147 (1), pp. 135-145. Date of Electronic Publication: 2020 Jan 24.
Typ publikacji :
Journal Article
MeSH Terms :
Positron-Emission Tomography*
Tumor Burden*
Brain Neoplasms/*diagnostic imaging
Brain Neoplasms/*metabolism
Cell Transformation, Neoplastic/*metabolism
Dihydroxyphenylalanine/*analogs & derivatives
Glioma/*diagnostic imaging
Glioma/*metabolism
Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/pathology ; Cell Transformation, Neoplastic/pathology ; Dihydroxyphenylalanine/pharmacokinetics ; Female ; Glioma/pathology ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Sensitivity and Specificity ; Survival Analysis ; Young Adult
Czasopismo naukowe
Tytuł :
Multicentric breast cancer with heterogeneous histopathology: a multidisciplinary review.
Autorzy :
Corso G; Faculty of Medicine, University of Milan, Milan, Italy.; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Magnoni F; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Provenzano E; NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Girardi A; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Iorfida M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.
De Scalzi AM; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Invento A; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Colleoni M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.
Cassano E; Division of Breast Imaging, European Institute of Oncology, IRCCS, Milan, Italy.
Trentin C; Division of Breast Imaging, European Institute of Oncology, IRCCS, Milan, Italy.
Gullo RL; Division of Breast Imaging, European Institute of Oncology, IRCCS, Milan, Italy.
Pravettoni G; Faculty of Medicine, University of Milan, Milan, Italy.; Applied Research Division for Cognitive & Psychological Science, European Institute of Oncology, IRCCS, Milan, Italy.
Gilardi L; Division of Nuclear Medicine, European Institute of Oncology, IRCCS, Milan, Italy.
Grana CM; Division of Nuclear Medicine, European Institute of Oncology, IRCCS, Milan, Italy.
Intra M; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Galimberti V; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Veronesi P; Faculty of Medicine, University of Milan, Milan, Italy.; Division of Breast Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
De Lorenzi F; Division of Plastic & Reconstructive Surgery, European Institute of Oncology, IRCCS, Milan, Italy.
Leonardi MC; Division of Radiation Oncology, European Institute of Oncology, IRCCS, Milan, Italy.
Pokaż więcej
Źródło :
Future oncology (London, England) [Future Oncol] 2020 Mar; Vol. 16 (8), pp. 395-412. Date of Electronic Publication: 2020 Feb 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Tumor Burden*
Breast Neoplasms/*diagnosis
Breast Neoplasms/etiology ; Breast Neoplasms/mortality ; Breast Neoplasms/therapy ; Combined Modality Therapy ; Disease Management ; Disease Susceptibility ; Female ; Genetic Predisposition to Disease ; Humans ; Lymphoscintigraphy ; Multimodal Imaging/methods ; Neoplasm Grading ; Neoplasm Staging ; Prognosis ; Retreatment ; Sentinel Lymph Node Biopsy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma.
Autorzy :
Strijker M; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Soer EC; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
de Pastena M; Department of General and Pancreatic Surgery, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.
Creemers A; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Balduzzi A; Department of General and Pancreatic Surgery, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.
Beagan JJ; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.
Busch OR; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Delden OM; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Halfwerk H; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Hooft JE; Department of Gastroenterology and Hepatology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Lienden KP; Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Marchegiani G; Department of General and Pancreatic Surgery, The Pancreas Institute, University of Verona Hospital Trust, Verona, Italy.
Meijer SL; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Noesel CJ; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Reinten RJ; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Roos E; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Schokker S; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Verheij J; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van de Vijver MJ; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.
Waasdorp C; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands.
Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Ylstra B; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, VU University Amsterdam, Amsterdam, The Netherlands.
Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Bijlsma MF; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Oncode Institute, Amsterdam, The Netherlands.
Dijk F; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
van Laarhoven HW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2020 Mar 01; Vol. 146 (5), pp. 1445-1456. Date of Electronic Publication: 2019 Aug 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Tumor Burden*
Biomarkers, Tumor/*blood
Carcinoma, Pancreatic Ductal/*mortality
Circulating Tumor DNA/*blood
Liver Neoplasms/*mortality
Pancreatic Neoplasms/*mortality
Aged ; Biomarkers, Tumor/isolation & purification ; Carcinoma, Pancreatic Ductal/blood ; Carcinoma, Pancreatic Ductal/secondary ; Circulating Tumor DNA/isolation & purification ; Female ; Follow-Up Studies ; High-Throughput Nucleotide Sequencing ; Humans ; Liver Neoplasms/blood ; Liver Neoplasms/secondary ; Male ; Middle Aged ; Pancreatic Neoplasms/blood ; Pancreatic Neoplasms/pathology ; Prognosis ; Prospective Studies ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies